Highlights  Two hits chronic stress paradigm results in colon microbiome changes with increased abundance of Clostridium.
Introduction
There is a functionally relevant communication between gastrointestinal tract (GIT), gut microbiome and central nervous system, referred to as gut-brain axis (Bravo et al., 2012; Cryan and O'Mahony, 2011) . This communication occurs via enteric-, autonomic-, neuroendocrine-and immune system pathways (Rieder et al., 2017 ). An increasing number of studies indicate that chronic stress affects composition and microbial balance of gut microbiome and may lead to serious dysbiosis (Bharwani et al., 2016; Golubeva et al., 2015; Mayer et al., 2014) . In addition, chronic psychological stress and early life adversity result in specific behavioral alterations, by increasing anxiety and depressive symptoms (McCormick and Green, 2013; Slattery et al., 2012; Strekalova et al., 2004) , changes in coping strategy (Cerniauskas et al., 2019; Winkler et al., 2017) and cognition (Herman et al., 1995; Sandi, 2004) . Although these stress-induced psychopathologies in human are accompanied by changes in the microbiome, the cause and effect relationship still remains unknown (Rieder et al., 2017) . In laboratory rodents, some of stress-induced behavioral alterations can be "transmitted" to normal animals by fecal transplants, indicating a role of the microbiome in shaping behavioral performance (Langgartner et al., 2018) .
Along with changes in the microbiome, chronic stress influence host barrier functions and result in "leaky gut" which underpins the chronic low-grade inflammation, observed in stressrelated anxiety and depression (Kelly et al., 2015; Leclercq et al., 2012) . Proinflammatory mediators, released in response to endotoxemia, increase hypothalamo-pituitaryadrenocortical axis activity and may exaggerate hormonal and behavioral stress responses.
Though the field advanced in the past ten years, the specific, complex relationship between stress, gut microbiome, inflammation and brain function is still not fully revealed (Moloney et al., 2016; Scott et al., 2017; Slyepchenko et al., 2016) . For instance, it is not known if overgrowth of pathogenic bacteria at the expense of commensals interferes with neuroendocrine, immune and behavioral changes during chronic stress.
Rifaximin is a non-absorbable, non-systemic, GIT-specific antibiotic, which selectively eliminates pathogenic bacteria (Kane and Ford, 2016) and relieves diarrhea associated with Clostridium difficile infections (Rubin et al., 2011) . More recently, microbiome-independent anti-inflammatory effects of rifaximin have also been reported in cases of post-infection diarrhea (Jin et al., 2018) .
Emerging studies indicate that psychobiological functions can be manipulated through the microbiome (Dinan et al., 2013; Warda et al., 2019) , therefore, the aim of this study was to test the hypothesis if rifaximin treatment restores chronic stress-induced gastrointestinal and inflammatory symptoms and changes in microbiome along with stress-induced changes in anxiety-like behavior.
Materials and methods

Experimental animals
Experiments were performed on male C57BL/6J mice. Animals were born and housed at the minimal disease (MD) level of Medical Gene Technology Unit at the Institute of Experimental Medicine. All experimental animals were from second litter of the breeding pairs. On PND0 the litter size was equalized to 5 by removing female offspring. 
Experimental design
In this experiment "two hits chronic stress paradigm" was used. Starting at postnatal day 1, pups were separated from their mother (maternal separation MS) for 3 hours daily for 12 days (early life stress -first hit). Pups were weaned at 21 days and kept 2-3/cage. At the age of 50 days, mice were exposed to chronic variable stress paradigm (CVS -second hit). In CVS, mice were stressed for 4 weeks, two times daily by different psychogenic stressors (social defeat, water avoidance, light/dark changes, forced swimming, soaked bedding, slanted cages, isolation, crowding, shaking, restraint, foot shock, rat feces odor). Daily schedule of the stressors is found in the Supplementary material. During chronic variable stress, half of the animals received 300 mg/kg bw/day rifaximin, a non-absorbable antibiotic (Sigma). Animals from different litters were randomly assigned to rifaximine/vehicle groups. Rifaximin was dissolved in 5% hypromellose solution in drinking water. The other half of mice (controls) received 5% hypromellose to drink. The fluid intake and body weight of the animals was monitored and rifaximin concentration in the drinking water was adjusted.
Control animals were left undisturbed except once a week change of bedding. Control mice were also randomly divided into rifaximin-treated and vehicle-treated subgroups. With this grouping, four experimental groups were formed: 1: MS+CVS, rifaximin-treated; 2: MS+CVS, vehicle treated; 3: No stress, rifaximin treated; 4: No stress, vehicle treated.
Experimental design and timeline diagram is shown on Figure 1 .
Fig. 1.
Overview of the experimental design. MS: Maternal separation (3h daily); CVS: Chronic variable stress (2x daily); OF: Open field test; EPM: Elevated plus maze test.
Behavior tests
Sucrose consumption test was performed before CVS and one day after chronic stress.
Mice had free choice for 24h between two bottles: one with 1% sucrose solution and the other filled with tap water. The position of the two bottles was switched after 12h. Sucrose and tap water intakes were assessed by weighing bottles. The sucrose consumption was expressed as a percentage of total liquid intake. As we did not habituate the animals to sucrose, this test measures neophobia rather than sucrose preference.
Anxiety-like behavior was studied in open field and elevated plus maze tests. In open field test, mice were placed in the center of a 40x40x30cm, white, non-transparent plastic box and their exploration was recorded from above for 10 min and then analyzed by the Noldus EthoVision XT 10 program. The open field was divided into 16 squares by a 4x4 grid in the software. The four inner squares of the grid were considered as central area. The apparatus was cleaned with tap water and paper towel between subjects.
The first five minutes of the mouse behavior in the open field was analyzed by Solomon Coder software. Four different behavior elements were differentiated in this analysis: walk, survey, rearing and grooming. The analysis was carried out by two individuals blinded to subject treatment group. Walking was noted when the mouse changed its location or turned as long as the front paws moved. Surveying was noted when all paws were on the floor and head directed upwards. Rearing was noted when two hind legs were on the floor and head directed upwards.
The elevated plus maze (arm length-30 cm, arm width-7 cm, wall height-30 cm platform height-80 cm) apparatus was made of dark-grey painted plexiglas. Open arms were surrounded by 0,3 mm high ledges. Mice were placed into the central area of the platform facing to one of the open arms and were allowed to explore the apparatus for 5 min. Mice were considered to enter a compartment when all four legs crossed the lines separating the compartments. Videos were analyzed by Noldus Observer software. Percentage of time spent in closed arms was used to measure anxiety-like behavior. The platform was cleaned with tap water and paper towel between subjects.
General procedure
At the end of the experiment, after decapitation (30 min after EPM) trunk blood was collected on EDTA and plasma stored at -20°C. This blood sample was regarded as a measure of stress-induced CORT, as it was collected at the time of maximal adrenocortical CORT release provoked by EPM exposure as stressor. Adrenal glands, thymus, interscapular brown adipose tissue (BAT), epididymal and subcutaneous white adipose tissues (eWAT and sWAT) were collected, cleaned and weighed for each mouse. Organ weights were normalized to final body weight and expressed as mg/g bw. Colon, mesenteric lymph nodes, liver and colon content were harvested and stored at -70°C until assay.
Gut permeability test in vivo
To assess gut permeability, a new set of chronically stressed and control animals (n= 22) were used. Half of these animals received vehicle or rifaxinine (300 mg/kg) as above. After overnight of fasting, all animals received FITC-labeled 4kDa Dextran (Sigma-Aldrich) via oral gavage (dose: 44 mg/kg; 100 mg/ml). 2 hours later, 250-300 µl blood was collected from the heart, centrifuged and serum was collected. Serum samples were diluted with an equal volume of PBS and FITC concentration was measured from 100 µl of diluted serum at excitation 485nm and emission 535nm wavelength using Cytation 5 Cell Imaging Multimode reader (Biotek Instruments). Standard curve was obtained by serial dilution of FITC-dextran solution in PBS (range: 0-16000 ng/ml). Equal volume of non-hemolytic serum from nongavaged mice was added to the serial dilution before measurement. The intra-and interassay coefficient of variation was 5.1% and 6.7%, respectively.
Hormone, endotoxin, glucose and triglyceride measurement from plasma
Plasma corticosterone was measured from 10µl plasma by direct RIA as described Zelena et al. (Zelena et al., 2003) . The intra-and interassay coefficient of variation was 12.3% and 15.3%, respectively.
To determine plasma endotoxin levels, commercially available limulus amebocyte lysate (LAL) assay was used in accordance of the manufacturer's instructions (Pierce LAL Chromogenic Endotoxin Quantitation Kit, Thermo Scientific). The intra-and interassay variances were: 5.3 and 5.6 CV% respectively.
Plasma glucose level was determined by Glucose Colorimetric Detection Kit from plasma according to the manufacturer's protocol (Glucose Colorimetric Detection Kit, Invitrogen).
For this assay, the intra-and interassay variances were: 6.1 and 9.2 CV% respectively. Plasma triglyceride (TG) level was measured by multiparameter diagnostic device for triglycerides (MultiCare-in; Biochemical Systems International Srl).
Gene expression analysis
Frozen colon tissue samples were homogenized by Bertin Technology Minilys homogenizer in 300 µl TRI reagent. Then, total mRNA was isolated from the homogenate using a Total mRNA Mini Kit (Geneaid) according the manufacturer's instruction. To eliminate genomic DNA contamination, DNase I (Fermentas) treatment was used. Sample quality control and the quantitative analysis were carried out by NanoDrop (Thermo Scientific). cDNA synthesis was performed with High Capacity cDNA Reverse Transcription Kit (Applied Biosystems). Real-Time PCR was carried out in ABI StepOnePlus instrument (Applied Biosystems) with Fast EvaGreen quantitative PCR master mix (Biotium) and genespecific primers. Primers (Microsynth) were designed in our laboratory using Primer-BLAST software of the National Center for Biotechnology Information (NCBI). Forward and reverse primers used to quantify mRNA are listed in Supplementary table 2. Gene expression was analyzed by the 2 -ΔΔCT method using the ABI StepOne Software v2.3 (Applied Biosystems).
The amplicons were tested by melt curve analysis on ABI StepOnePlus instrument (Applied Biosystems). Relative changes in gene expression were normalized against GAPDH mRNA expression. Reference gene was selected based on the NormFinder software (Andersen et al., 2004 ).
Microbiome analysis
Total DNA was extracted from 200 mg colon content using QIAamp DNA Stool Mini Kit Supplementary table 3 . The primer specificity was tested by Melt Curve Analysis.
DNA samples were diluted to the same concentration 5ng/µl. Quantification was done by using standard curves made from known concentrations of the respective amplicon for each set of primers. Gene expression was analyzed using ABI StepOne v2.3 program (Applied Biosystems). The results are expressed in copy number (CN) and it was calculated with the following formula: CN = A*6x10 23 /(L*660)*1x10 9 ng/g; where A is the amount of the amplicon in ng, L is the length of the amplicon.
Bacterial load in mesenteric lymph node
Mesenteric lymph nodes (MLN) were aseptically collected and stored at -70°C. Total DNA was isolated from MLN by Tissue Genomic DNA Mini Kit (Geneaid) according to the manufacturer. DNA concentration and quality control was checked by using NanoDrop (Thermo Scientific). Samples were diluted to the same DNA concentration. Then total DNA was amplified targeting bacterial 16S rRNA gene by using an universal bacterial primer (Supplementary table 2.). Amplification was processed by RT-PCR as described in 2.6.
Histology
After decapitation, a colon sample was removed, cleaned and placed immediately into 10% buffered paraformaldehyde (pH=7.4) for 24 h. Fixed tissue was embedded in paraffin and sectioned 5 µm thick sections in two parallel series. One series was deparaffinized and stained with haematoxylin & eosin (H&E). Images of stained colon sections were captured under 20x magnification with Spot RT color digital camera on Nikon Eclipse 6000 microscope. Mucosa thickness was measured by using ImageJ software, in a blinded manner. From each mouse, five sections were randomly selected, from each section, 10 measurements were done and averaged.
F4/80 (murine macrophage marker) immunostaining was performed on the second series of colon sections by standard immunohistochemical protocol. Slides were deparaffinized and rehydrated. Antigen retrieval pretreatment was performed with proteinase K (Sigma; 10 mg/ml; diluted 1:25 in digestion puffer: 1M Tris and 0,5M EDTA). Then, endogenous peroxidase was blocked by 0,3% H 2 O 2. Next, slides were washed in KPBS (0,01M potassium phosphate buffer, 0,154 M NaCl) and incubated in 2,5% normal rabbit serum for 1 hour to avoid nonspecific binding. Sections were incubated in anti-mouse F4/80 antibody made in rat (BMA Biomedicals, T-2008; 1:50) overnight at 4°C. After washing, sections were incubated in biotinylated secondary antibody (Vector Laboratories, 1:250) for 1 h. Then, immunoreactivity was visualized with Alexa Fluor TM 488 Tyramide SuperBoost TM Kit, according to the manufacturer's instructions (Invitrogen by Thermo Fisher Scientific). Slides were coverslipped with DAPI Fluoromount-G ® (SouthernBiotech) and scanned with Pannoramic ® MIDI II Slide Scanner. Images were analyzed with Caseviewer 2.3. software by two different investigators, who were blinded to treatment. For quantitative analysis of the area% occupied by F4/80 immunoreactivity, ten images from each mouse were randomly selected and re-opened in Image J software. All images were set at a common threshold level and F4/80 positive areas were selected. Background subtraction procedure was performed equally in each image. The entire immunoreactive area fraction was then automatically measured by the program, with the same threshold. Area % was measured separately for submucosa and lamina propria.
Statistical analysis
Data are shown as means ± SEM. Statistical analysis was performed by two-way ANOVA (GraphPad Prism 7) followed by Sidak's multiple comparison test. Sugar preference data was analyzed by repeated-measures ANOVA followed by Sidak's post hoc test, time being the repeated measure. In case of preCVS body weight data, unpaired t-test was used. In all cases, differences were considered statistically significant at p<0.05.
Results
Behavior tests
Ethogram
To examine the effects of chronic stress and rifaximin on mouse behavior, we observed and quantified four distinct elements: walking, surveying, rearing and grooming during 5 min in novel environment ( Fig.2A) . Compared to no-stress controls, all mice which have been 
Open field, EPM, sucrose consumption
Increased locomotion was detected during the open field test in MS+CVS mice. Velocity [F(1, 41)= 24.24; p<0.0001] and distance moved [F(1, 41)= 24.29; p<0.0001] was higher in chronically stressed mice (Fig.3A-B ). In addition, stressed mice spent less time in the center [F(1, 41)= 10.38; p=0.0025] and their first latency to border was shorter than those of controls [F(1, 41)= 12.65; p<0.0010] (Fig. 3C-D) .
To reveal anxiety-like behavior after MS+CVS, elevated plus maze test was performed. As shown in Fig. 3 .F preference for the open arms of stressed mice was significantly lower compared to control animals [F(1, 28)= 13.95; p=0.0009]. Average entries into the open arms,
first latency to open and closed arm were also analyzed, however, we did not detect significant differences in these parameters ( Supplementary Fig. 1.) .
Neophobia was assessed by sucrose consumption tests before and after the chronic stress procedure (Fig.3G) . MS+CVS resulted in a significant decrease of sucrose consumption (novelty) in stressed mice [t=4.148; DF=19; p=0.0022] and the same reduced sucrose consumption was seen in CVS+antibiotic treated mice [t=3.251; DF=19; p=0.0167], however, there was no difference in control groups. In each behavior tests (novel environment, open field, elevated plus maze and sucrose consumption based neophobia) rifaximin treatment had no effect. and exploration maps of the experimental mice (E). Open arm preference in elevated plus maze test (F). Data were analyzed by two-way ANOVA (n=9-14 per group). Mean ± SEM values, **p<0.01, ****p<0.0001 vs. control group. Sugar consumption of experimental mice before and after CVS procedure (G). Data were analyzed by repeated measures two-way ANOVA followed by Sidak's multiple comparison test (n=5-7 per group). Mean ± SEM values, *p<0.05, **p<0.01 vs. control group.
Changes in body and organ weights
T-test revealed significant pre-CVS body weight difference between mice with postnatal maternal separation and controls [t=2.69, df =20, p=0.014] (Fig.4A ). During chronic variable stress, weight gain between experimental groups was not significantly different [F(1,18)= 0.2027; p=0.8884)] (Fig.4B ).
Normalized adrenal weight was higher in all MS+CVS exposed mice than in controls [F(1, 19)= 4.512; p=0.047] (Fig.4C ). Two way ANOVA did not reveal drug (rifaximin) effect. Fig. 4 . Effect of chronic stress and rifaximin treatment on body weight gain and organ weights. Body weight difference before CVS (at PND50) (A) and body weight gain during CVS (B). Normalized organ weights (C). Mean ± SEM. Data were analyzed by two-way ANOVA (n=5-7 per group). In case of preCVS body weight unpaired t-test was used. *p<0.05, **p<0.01, ****p<0.0001 vs. control groups.
Hormones and metabolic markers
During CVS procedure, basal (morning), pre-stress corticosterone levels were significantly higher in CVS exposed mice than in controls [F(1, 18)= 7.181; p=0.0153]. Two way ANOVA indicated no drug effect [F(1, 18)= 0.1965; p=0.6629] (Fig.5A ).
Analysis of plasma corticosterone concentrations after acute EPM exposure revealed no significant differences among the treatment groups [F(1, 19)= 0.226; p=0.6399] (Fig.5B ).
Plasma glucose levels following acute stress were elevated in chronically stressed mice compared to controls [F(1, 13)= 22.44; p=0.0004] (Fig.5C ).
In addition, post hoc test revealed elevated plasma TG level in stressed mice [t=2.627; DF=18; p=0.0339 compared to vehicle control], while there was no difference between the two, antibiotic treated groups (Fig.5D ). 
Colon microbiome analysis
Antibiotic treatment reduced total DNA concentration in the colon content (Fig.6A) .
Interestingly, colonic DNA concentration in MS+CVS+vehicle treatment group was more reduced than that of the antibiotic treated mice and it was significantly decreased compared to the control group [t=2.558; DF=17; p=0.0403], suggesting that the abundance of microbiome in the colon is substantially reduced by stress treatment.
Colon microbiome diversity was analyzed at the phylum level and the results showed an increased abundance in the phylum of Bacteriodetes [F(1,17) =5.844; p=0.0272] and Proteobacteria in response to stress, nevertheless rifaximin treatment significantly attenuated stress-induced Proteobacteria abundance [t=2.665; DF=17; p=0.0324 compared to control, t=2.581; DF=17; p=0.0385 compared to antibiotic treatment] (Fig.6B) . Changes in Firmicutes, Actinobacteria, Verrucomicrobia and Cyanobacteria were not significant ( Fig.6B-C) . Amount of Clostridium sp. was determined at genus level. Chronic stress resulted in increased abundance, however antibiotic treatment normalized this stress-induced elevation [t=2.707; DF=17; p=0.0297 compared to control, t=3.233; DF=17; p=0.0098 compared to vehicle] (Fig.6D) . 
Colon mucosa, tight junction protein expression and gut permeability
MS+CVS significantly reduced the thickness of mucosa compared to control [t=3,082; DF=19; p=0.0122]. Mucosa thickness was not different in rifaximin-treated groups (Fig.7A,   B ). Colonic mRNA expression ( Fig.7C) Next, we used FITC-labeled 4kDa dextran assay to test gut permeability in vivo and found increased gut permeability in chronically stressed mice, while rifaximin treatment of these animals restored the normal, non-stressed values [t=2.72; DF=18; p=0.0301 compared to control, t=3.449; DF=18; p=0.0066 compared to vehicle, interaction: F(1, 18)= 6.109; p=0.0251] (Fig.7D) . 
Gut permeability, macrophage infiltration, local-and systemic bacterial load
Next, we checked whether increased gut permeability results in local piling of macrophages. In control, vehicle-treated mice the immunoreactivity corresponding to macrophage marker F4/80 was primarily confined to the submucosa. Essentially the same distribution was revealed in non-stressed, rifaximin-treated mice (Fig. 8A) . However, in MS-CVS mice, an increase of F4/80 positive profiles and macrophage infiltration to the lamina propria was detected. Rifaximin treatment of MS-CVS animals restored the distribution of F4/80 positive macrophages to that seen in control animals (Fig.8A) . Quantitative histological analysis of F4/80+ areas revealed significant rifaximin effect in the submucosa [F(1, 19)= 6.316; p=0.0211]. In the lamina propria of MS-CVS animals, the area covered by F4/80+ profiles was significantly increased in stressed mice, which was reduced to that of the controls in response to rifaximin treatment [t=14.69; DF=19; p<0.0001 compared to control, t=14.78; DF=19; p<0.0001 compared to vehicle, interaction: F(1, 19)= 105.4; p<0.0001], (Fig. 8B) .
Gut lymphatics are drained in mesenteric lymph nodes, which gate intestinal bacteria and pathogen-associated molecular patterns, PAMPs. To assess bacterial translocation in chronically stressed mice, we PCR-amplified bacterial DNA from mesenteric lymph nodes using common 16S ribosomal primers. Compared to non-stressed controls, chronic stress resulted in 50% elevation of bacterial load in the MLN [t=2.781; DF=18; p=0.0245].
Rifaximin administration interfered with stress-induced increase of bacterial load (Fig. 8C ).
To reveal if chronic stress induces systemic endotoxemia, plasma LPS levels were measured. Higher LPS level was detected in plasma of stressed mice than in the controls [t=2.61; DF=18; p=0.0351] but the increase of plasma LPS was not detected in antibiotic treated mice (Fig. 8D) . Representative images of F4/80 immunostained colon sections showing distinct macrophage distribution (green-F4/80) in stressed and rifaximin-treated animals (on blue-DAPI background). (Scale bar: 100µm) (A). Quantitative analysis of F4/80 immunostaining in the submucosa and lamina propria (B). Bacterial load in the mesenteric lymph node expressed as % of control-vehicle group (C). Plasma LPS concentration in control, MS+CVS groups, with or without rifaximin treatment (D). Data were analyzed by two-way ANOVA, followed by Sidak's multiple comparison test (n=5-7 per group). Mean ± SEM values, *p<0.05, **p<0.01, vs. control group, #p<0.05, ##p<0.01, ###p<0.001, vs. corresponding vehicle group.
Discussion
In the present study we demonstrate that "two hits" chronic stress affects colon microbiome, impairs gut barrier functions, resulting in leaky gut as demonstrated by macrophage invasion to colon mucosa and increased local-and systemic bacterial load. These changes are accompanied by signs of increased anxiety-like behavior and neophobia in stressed mice. Rifaximin, a non-absorbable, gut specific antibiotic, given to chronically stressed mice, alleviated stress-induced increase of Clostridia, improved gut permeability, mucosal erosion and inflammation, however had no impact on the stress-induced behavior.
Somatic (adrenal enlargement)-, hormonal (elevated plasma CORT)-and metabolic (increased WAT depots, hyperglycemia and hyperlipidemia) parameters validated the present MS-CVS model as chronic stress in mice (Zelena et al., 2005) . Interestingly, stress-induced thymus involution was not detected, in spite of elevated basal CORT levels.
There is a well-documented mutual interaction between the gut microbiome and host stress response Foster et al., 2017) . Chronic stress is an important environmental factor, which triggers gut dysbiosis and in turn, altered microbiome has an impact on neuroendocrine-autonomic and behavioral aspects of the stress response. Growing evidence indicates a link between stress and microbial dysbiosis De Palma et al., 2014; Watanabe et al., 2016) . Previous studies from different laboratories revealed distinct stress-induced changes of the gut microbiome composition depending on the stressor (water avoidance (Xu et al., 2014; Yoshikawa et al., 2017) , repeated restraint (Maltz et al., 2018) , social defeat/disruption (Bailey et al., 2011; Langgartner et al., 2018; Werbner et al., 2019) and origin of bacterial sampling (fecal (Gautam et al., 2018) , luminal (Szyszkowicz et al., 2017) mucosal (Galley et al., 2014) . General conclusion of these studies is that chronic psychological stress results in outgrowth of Bacteroidetes and decrease the abundance of Firmicutes. Here we confirm and extend these observations to show that MS-CVS "two hits" paradigm is also capable to increase Bacteroidetes and Proteobacteria in chronically stressed mice, which is accompanied here with an overall decrease of total bacterial DNA concentration in the colon content.
A number of studies have identified early life adversity as an important factor affecting gut microbiome (Rincel et al., 2019) . Studies in rats, mice and Rhesus monkeys revealed decrease of microbial diversity following maternal separation (Bailey and Coe, 1999) or limited nesting (Moussaoui et al., 2016) . Here, we have used the "two hits" model of chronic adversity by combination of early life stress, maternal separation and chronic variable stress paradigm, both of which might have an impact on gut microbiome. Future work should reveal lasting changes and sensitization of postnatally stressed microbiome to challenges in adulthood.
Among the bacterial species studied here, the copy number of Clostridia increased significantly as a result of MS-CVS stress paradigm. This finding is in agreement with those of (Bailey et al., 2011; Pearson-Leary et al., 2019; Watanabe et al., 2016) . Although some Clostridia are pathogenic and are responsible for diarrhea in the elderly, we did not observed serious diarrhea or watery feces in our stressed mice.
Rifaximin, which is a non-absorbable antibiotic, specifically targets Clostridia and other Gram negative and positive bacteria. Therefore, we hypothesized that rifaximin treatment of mice exposed to MS-CVS will restore microbiome related gut-brain axis and behavioral changes to normal. Indeed, stress-induced Clostridia were significantly attenuated by antibiotic treatment. In addition, rifaximin administration prevented stress-induced increases of Proteobacteria, but not Bacteroidetes. These data confirm previous findings that rifaximin do not significantly affect the overall composition of the human fecal microbiome (Soldi et al., 2015) and only mild changes are observed in mice (Jin et al., 2018) . More recently, rifaximin was recommended for treatment of post-infectious irritable bowel disease (IBS) and related abdominal discomfort (Acosta et al., 2016) (Ponziani et al., 2016) . In search for the mechanism of rifaximin action, increased expression of gut tight junction proteins emerged (Jin et al., 2018) . We have confirmed increased mRNA levels of tight junction proteins occludin, tjp1 and tjp2, but not tjp3, in colon samples of stressed and non-stressed, rifaximin treated mice. Increased expression of tight junction proteins along with slightly increased muc2 indicates improved gut barrier function after rifaximin administration.
"Leaky gut" is generally held as a hallmark of chronic stress-related pathologies (Camilleri, 2019; Maes et al., 2007) . In the present MS-CVS model we did not detect stressinduced changes in colonic expression of tight junction proteins (Occludin, TJP1-3) and muc2. However, we did find significant decrease of mucosa thickness, signs of epithelial damage. Furthermore, increased transcellular transport was detected in the gut of chronically stressed mice by FITC-dextran method, indicating impaired barrier function (Fukui, 2016) .
The leaky barrier should allow various feed/microbiome related antigens to initiate local immune responses. Such an innate immune activation has been revealed by infiltration of F4/80 positive macrophages into the lamina propria of MS-CVS exposed mice, which was prevented by rifaximin treatment during chronic variable stress. Gut lymphatics are drained in mesenteric lymph nodes (MLN), where a significant bacterial load has been revealed in our chronically stressed mice. This finding is compatible with the report by (Velin et al., 2004) where 30 times increased E coli passage was detected in chronically stressed rats, ex vivo. In addition to this local bacterial translocation to MLN, significant elevation of LPS was detected in the plasma of MS-CVS mice, indicating systemic endotoxemia. Rifaximin administration during CVS prevented the increase of LPS plasma levels, suggesting that rifaximin effects go beyond anti-pathogenic activity. The endotoxemia reducing effects of rifaximin has already been shown in chronic liver disease (Bajaj et al., 2013) , however the mechanisms of action and molecular targets remain unknown.
Another noteworthy finding of this study is the stress-induced colonic upregulation of Reg3b. Reg3b is a C-type lectin, which belongs to antimicrobial peptide (AMP) family and involved in gut barrier functions (Shin and Seeley, 2019) . Further studies are required to clarify if increased expression of Reg3b mRNA may represent an adaptive compensatory host mechanism to impaired barrier and increased bacterial burden.
Chronic stress exposure is a risk factor for psychiatric disorders, such as anxiety and depression, subsets of which are accompanied or driven by activated immune system (Slattery et al., 2012) (Renault and Aubert, 2006) . Parallel to stress-induced microbiome changes, chronic stress increases gut permeability and results in a leaky gut, through which bacterial cell wall components might reach the systemic circulation, trigger toll like receptors and result in low grade systemic inflammation. LPS and related proinflammatory cytokines activate the HPA axis (Turnbull et al., 1998) and promote deterioration of stress-induced anxiety (Anisman et al., 2002) .
In search for the causal role of microbiome in the development of stress-related psychopathologies, Langgartner et al. showed that stress-induced psychobiological changes can be transmitted by fecal transplantation from stressed to non-stressed mice (Langgartner et al., 2018) . In contrary, our present results suggest that settlement of stress-induced changes in the gut does not alleviate MS-CVS-induced locomotor hyperactivity, anxiety-like symptoms in open field and elevated plus maze tests and anhedonia. One explanation for the resistance of stress-induced behavior to improvement of gut and immune functions would be the timing of rifaximin treatment. It is likely that behavior needs more time than gut to recover from CVS. Another possibility would be that early life adversity i.e. maternal separation results in permanent changes in the gut flora (Rincel et al., 2019) and behavior, which do not change after antibiotic treatment in the adulthood. Indeed, it has been shown that early life events result in epigenetic modulation of stress/anxiety-related genes such as hypomethylation of the Crh promoter in the PVN of maternally deprived adult rats (Chen et al., 2012) and reduction in histone H3 acetylation at human/rat glucocorticoid receptor (GR, NR3C1) promoter in the hippocampus (Suderman et al., 2012) .
Finally, rifaximin reduced pathogenic bacteria and improved gut barrier, however, did not enforce the abundance of beneficial "psychobiotic" bacteria. It has been shown that administration of certain Lactobacilli and Bifidobacteria have anxiolytic/antidepressive effects (Borre et al., 2014; Bravo et al., 2011; Dinan et al., 2013) .
Recent studies implicate that antibiotic usage in human and farm animals results in dysbiosis, provoke systemic inflammation, which might be responsible for long-term metabolic-(obesity), behavioral-and mental changes. However, we did not detect any significant behavioral changes in unstressed mice treated with antibiotic for 3 weeks. Future work should focus on the interaction between systemic antibiotics and stress in regulation of microbiota-gut-brain axis.
In conclusion, combination of early life adversity with adult chronic variable stress (CVS) paradigm in mice results in gut dysbiosis and impaired gut barrier function along with increased locomotor activity, anxiety-like behavior and neophobia. Rifaximin treatment during CVS decreases stress-induced pathogenic bacteria, restores gut barrier functions, reduces local and systemic bacterial load, however, does not improve stress-induced behavioral changes.
